Industry NewsPositive results from Adrenomed’s AdrenOSS-2 Phase II trial evaluating Adrecizumab (HAM8101) in septic shock presented during e-ISICEM
Product NewsFundamental Technology to Support the Early Diagnosis of Neurodevelopmental Disorders from Brain Response at First Medication
Scientific PostersDetermination of Organic and Inorganic Contaminants in Beer Using ICP-MS & LC-MSMS Spectrometry
Product NewsHORIBA Medical obtains CE Mark Certification for the new generation Microsemi CRP LC-767G